Syringes Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Material (Plastic, Glass), By End Use (Hospitals & Clinics, Blood Collection Centers, Ambulatory Care Centers, Others), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 15.67 Billion
CAGR (2026-2031)	6.1%
Fastest Growing Segment	Plastic
Largest Market	North America
Market Size (2031)	USD 22.35 Billion

Market Overview

The Global Syringes Market is projected to grow from USD 15.67 Billion in 2025 to USD 22.35 Billion by 2031 at a 6.1% CAGR. A syringe is a medical device engineered to inject or withdraw fluids from the body, typically comprising a calibrated barrel, a snugly fitting plunger, and often a detachable needle. The global syringes market experiences growth primarily driven by the increasing prevalence of chronic diseases necessitating frequent injectable treatments, the rising geriatric population requiring enhanced medical care, and the expansion of global immunization programs. These fundamental factors underscore the sustained demand for essential medical injection devices worldwide.

Supporting this demand, according to the UNICEF Supply Annual Report, in 2024, the organization delivered 886.19 million syringes globally. However, a significant challenge impeding market expansion involves the persistent raw material shortages and geopolitical factors causing supply chain disruptions, which increase production costs for manufacturers. This can impact product affordability and availability, particularly in price-sensitive markets.

Key Market Drivers

The rising prevalence of chronic and infectious diseases significantly influences the global syringes market, as these conditions often necessitate frequent injectable treatments, diagnostics, and ongoing disease management. Conditions such as diabetes, autoimmune disorders, and various infectious diseases rely heavily on syringes for drug administration and sample collection. For instance, according to the International Diabetes Federation (IDF) Diabetes Atlas 2025, approximately 589 million adults were living with diabetes globally in 2024, many of whom require daily insulin injections. This persistent demand for injectable therapies creates a foundational driver for syringe consumption worldwide.

Concurrently, increasing global immunization and vaccination initiatives represent another critical factor propelling the syringes market. Public health campaigns aimed at preventing infectious diseases through widespread vaccination programs require a continuous supply of syringes for mass inoculation efforts. These initiatives span routine childhood immunizations, seasonal flu vaccinations, and responses to emerging pandemics. According to data released by the World Health Organization (WHO) and UNICEF on July 15, 2025, approximately 109 million infants worldwide completed all three doses of the diphtheria, tetanus, and pertussis (DTP) vaccine in 2024, demonstrating the vast scale of these programs. Furthermore, a leading medical technology company, BD (Becton, Dickinson and Company), reported revenue of approximately $5.2 billion for its first fiscal quarter of 2025, ending December 31, 2024, reflecting the substantial economic activity within this sector.

Download Free Sample Report

Key Market Challenges

Persistent raw material shortages and geopolitical factors represent a significant challenge to the global syringes market, leading to substantial supply chain disruptions and increased production costs for manufacturers. These pressures stem from various global events and trade dynamics that directly influence the availability and pricing of essential components required for syringe manufacturing. According to Vizient, a healthcare performance improvement company, in its July 2025 Spend Management Outlook, prices for surgical supplies, a category inclusive of syringes, were projected to rise by 3.28% in 2026, primarily driven by increases in raw material prices, manufacturing labor costs, and fluctuating freight expenses.

Such elevated production expenses directly hamper market growth by impacting product affordability and availability, particularly within price-sensitive healthcare systems. Geopolitical tensions, as highlighted by AdvaMed in its Q4 2025 report, introduce uncertainty and potential tariffs that can further disrupt the medtech supply chain, reinforcing procurement challenges for essential materials. Manufacturers facing higher input costs may need to raise product prices, potentially limiting access to critical medical injection devices in regions with constrained budgets or increasing the financial burden on healthcare providers. These disruptions can also lead to delays in product delivery and regional shortages, directly impeding the consistent availability of syringes worldwide.

Key Market Trends

The global syringes market is significantly impacted by the growing preference for prefilled syringes, which streamline medication delivery and enhance patient safety. This trend is driven by the increasing need for convenient and accurate drug administration, particularly for complex biologics and self-injectable therapies used in home healthcare settings. Prefilled syringes reduce preparation errors, minimize contamination risks, and offer greater ease of use for both healthcare professionals and patients. For example, according to BD (Becton, Dickinson and Company) on January 13, 2026, the company announced a $110 million investment to expand its U.S. production of prefillable syringes, specifically to accelerate biologic and GLP-1 drug delivery and support pharmaceutical reshoring in the U.S.. This strategic investment highlights the industry's commitment to meeting the escalating demand for these advanced delivery systems.

Concurrently, the increased adoption of safety-engineered syringes represents another critical trend, primarily aimed at protecting healthcare workers from needlestick injuries and preventing the transmission of bloodborne pathogens. Regulatory mandates and heightened awareness regarding occupational safety continue to drive the demand for syringes equipped with features such as retractable needles or needle guards. These safety mechanisms are crucial in hospitals, clinics, and vaccination programs to mitigate risks associated with accidental sharps exposures. The focus on enhanced safety is underscored by reports like the 2023 EXPO-S.T.O.P. report, which indicated a sharps injury incidence rate of 2.0 per 100 full-time equivalent staff, based on data from 369 hospitals across 34 states. Such statistics emphasize the ongoing imperative for healthcare facilities to adopt safer injection devices to ensure a protected working environment.

Segmental Insights

The plastic segment is rapidly emerging as the fastest-growing in the Global Syringes Market, driven by its inherent advantages over traditional materials. Plastic syringes offer superior cost-effectiveness and manufacturing versatility, enabling high-volume production crucial for global healthcare needs. Their robust, shatter-resistant design significantly enhances safety for both patients and healthcare personnel by reducing the risk of accidental breakage and needle-stick injuries. This focus on safety aligns with the stringent guidelines and emphasis on single-use medical devices by regulatory bodies such as the U.S. Food and Drug Administration. The increasing demand for single-use and pre-filled syringes, essential for infection control and supporting extensive vaccination programs and managing chronic diseases, further propels the segment's expansion.

Regional Insights

North America leads the global syringes market due to its advanced healthcare infrastructure and substantial healthcare expenditure. The region experiences high demand driven by the increasing prevalence of chronic diseases, such as diabetes requiring frequent injections, and robust vaccination programs. Furthermore, the presence of major medical device manufacturers, coupled with stringent regulatory oversight from bodies like the U.S. Food and Drug Administration (FDA) and Health Canada, ensures the production and adoption of high-quality, safe, and innovative syringe technologies. This supportive environment fosters continuous growth and market dominance.

Recent Developments

• In January 2026, Becton, Dickinson and Company (BD) announced a substantial $110 million investment to expand its production of prefillable syringes. This strategic move focused on establishing BD Neopak™ Glass Prefillable Syringe manufacturing at its facility in Columbus, Nebraska. The investment was intended to strengthen the pharmaceutical supply chain and accelerate the delivery of biologic and glucagon-like peptide-1 (GLP-1) drugs. BD anticipated that supply from these new production lines would begin by mid-2026, reinforcing its commitment to supporting advanced drug delivery solutions in the global syringes market.
• In August 2025, Becton, Dickinson and Company (BD) announced an investment exceeding $35 million to expand the manufacturing of its BD PosiFlush™ Prefilled Flush Syringes at its Columbus, Nebraska facility. This strategic expansion aimed to significantly boost production capacity, enabling the company to supply hundreds of millions of additional units annually. The initiative was part of BD's broader commitment to bolstering the resilience of the U.S. healthcare infrastructure, ensuring a reliable supply of essential prefilled syringes for hospitals and health systems across the nation. The investment also supported product innovation and operational efficiencies within the global syringes market.
• In April 2025, Gerresheimer, an innovative systems and solutions provider, introduced new silicone-oil- and PFAS-free syringe systems, developed in cooperation with Injecto Group A/S. These ready-to-fill syringe systems, available in both glass and cyclic olefin polymer, were designed to offer a safer solution for sensitive biologics and specialized applications like ophthalmology. The collaboration ensured the long-term availability of Injecto's patented plunger stoppers, significantly reducing particle contamination and minimizing potential medical risks within the global syringes market.
• In January 2025, SCHOTT Pharma launched its next-generation SCHOTT TOPPAC® infuse polymer syringe system, in collaboration with Schreiner MediPharm and Körber Pharma. This innovative system aimed to enhance safety, efficiency, and sustainability within the global syringes market. Key features included a new cap design for individual syringe tamper evidence, an integrated label concept with options for oxygen and light protection, and the potential for an RFID chip for improved drug traceability. Additionally, carton secondary packaging was implemented to reduce waste and optimize storage.

Key Market Players

• Becton Dickinson and Company
• Terumo Corporation
• Medtronic plc
• B. Braun Medical Inc.
• Nipro Corporation
• Hindustan Syringes & Medical Devices Ltd.
• Gerresheimer AG
• SCHOTT AG
• CODAN Medizinische Geräte GmbH
• Baxter Healthcare Corporation

By Material	By End Use	By Region
Plastic Glass	Hospitals & Clinics Blood Collection Centers Ambulatory Care Centers Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Syringes Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Syringes Market , By Material:

• Plastic
• Glass

• Syringes Market , By End Use:

• Hospitals & Clinics
• Blood Collection Centers
• Ambulatory Care Centers
• Others

• Syringes Market , By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE